Health Catalyst (HCAT) Misses Q4 Earnings and Revenue Estimates
Portfolio Pulse from
Health Catalyst (HCAT) reported Q4 earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.11. This is an improvement from $0.02 per share a year ago.
February 27, 2025 | 12:30 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Health Catalyst reported Q4 earnings of $0.04 per share, missing the expected $0.11. Despite the miss, earnings improved from $0.02 a year ago.
The earnings miss is likely to negatively impact HCAT's stock price in the short term as it failed to meet analyst expectations. However, the year-over-year improvement in EPS may mitigate some negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100